Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 9,030Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    29/11/2025 Tokyo Chemical Industry
    Japan
    		 Tokyo Chemical Industry Co., Ltd. 217MF11160 Neostigmine bromide 2005-12-12 2006-10-20 6-15-9 Toshima, Kita-ku, Tokyo
    29/11/2025 Tokyo Chemical Industry
    Japan
    		 Tokyo Chemical Industry Co., Ltd. 217MF11158 Neostigmine methylsulfate 2005-12-12 2006-10-20 6-15-9 Toshima, Kita-ku, Tokyo